Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's disease.

Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's disease. medRxiv : the preprint server for health sciences Chiotis, K., Blazhenets, G., Soleimani-Meigooni, D. N., Aisen, P. S., Amuiri, A., Atri, A., Beckett, L., Brickhouse, M., Clark, D. G., Dage, J. L., Day, G. S., Duara, R., Eloyan, A., Foroud, T., Graff-Radford, N. R., Grant, I. M., Hammers, D. B., Honig, L. S., Johnson, E. C., Jones, D. T., Kirby, K., Koeppe, R., Kramer, J. H., Kukull, W. A., Lagarde, J., Leuzy, A., Maiti, P., Masdeu, J. C., Mendez, M. F., Musiek, E., Nudelman, K. N., Onyike, C. U., Riddle, M., Rocha, S., Rogalski, E., Salloway, S., Schonhaut, D. R., Sha, S., Shankar, R., Taurone, A., Thangarajah, M., Toga, A. W., Touroutoglou, A., Turner, R. S., Vemuri, P., Wingo, T. S., Wolk, D. A., Womack, K., Zhang, J., Carrillo, M. C., Dickerson, B. C., Apostolova, L. G., La Joie, R., Rabinovici, G. D. 2026

Abstract

Early-onset Alzheimer's disease (EOAD) and Late-onset AD (LOAD) differ in clinical presentations and rates of progression. We aimed to compare baseline and longitudinal tau PET burden, and their relationship with clinical variables in amyloid-PET positive, cognitively impaired participants from the Longitudinal Early-Onset Alzheimer's Disease Study (EOAD; n=390) and Alzheimer's Disease Neuroimaging Initiative (LOAD; n=211). Patients with EOAD showed higher baseline tau PET retention, broader neuroanatomical involvement and faster accumulation rates over time compared to LOAD, after adjusting for amyloid load and clinical stage. Tau PET showed stronger correlations with baseline amyloid burden and clinical measures of global cognition and function in EOAD than LOAD. We conclude that earlier age of onset in AD is linked to a more aggressive tauopathy, which in turn is a primary driver of clinical decline. These findings suggest that optimal therapeutic targets and strategies may differ between EOAD and LOAD.

View details for DOI 10.64898/2026.01.25.26344738

View details for PubMedID 41646765

View details for PubMedCentralID PMC12870685